Feedback / Questions
Igalmi (dexmedetomedine sublingual) - BioXcel
https://www.globenewswire.com/news-release/2025/08/26/3139590/0/en/BioXcel-Therapeutics-To-Announce-Topline-Results-from-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Bipolar-Disorders-or-Schizophre.html
Aug 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next